12:00 AM
 | 
Mar 22, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Dirame propiram: Phase III

Roberts said that preliminary results of its 350-patient Phase III trial of Dirame to treat post-operative dental pain showed statistically significant analgesic effects at doses of 50 mg and above. Patients who had 2 or more third...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >